title: Epstein-Barr Viral Load is Associated to Response in AIDS-Related Lymphomas.
abstract: AIDS-related lymphoma (ARL) development is associated to immunodeficiency state with proliferation of B-cells driven by HIV itself and EBV infection. However, Epstein-Barr DNA is not detected in malignant cells of all ARL subtypes. A prospective and controlled study to analyze EBV viral load (VL) in plasma and peripheral blood mononuclear cells (PBMC) of ARL patients was performed to analyze if Epstein-Barr VL could be related to response in these patients. Fifteen patients with ARL were included in this study with measurement of EBV VL at three different periods of time: at lymphoma diagnosis, upon completion of chemotherapy, and 3 months after. Two control groups composed by HIV-negative and HIV-positive patients were also evaluated for EBV VL comparison. In situ hybridization for EBER was performed on diagnostic samples of all ARL patients. Median EBV VL in PBMC and plasma had a significant decrease (p = 0.022 and p = 0.003, respectively) after ARL treatment. EBER was positive in 7 (46.7 %) cases. Median EBV VL in PBMC before lymphoma treatment in patients positive for EBER was significantly higher compared to EBER negative cases (p = 0.041). Reduction of EBV viral load during treatment of lymphoma could be predictive of response. EBER expression was associated to advanced stages of disease and worse immune status. Our study suggests that measurement of EBV VL during ARL treatment could be used as a marker for response, but further studies are needed to validate this association.
authors.affiliation: Faculdade de Medicina - Programa de Ciências Médicas, Universidade de São Paulo, Av. Dr. Arnaldo, 455, São Paulo, Brazil.
authors.forename: Paula Yurie
authors.initials: PY
authors.lastname: Tanaka
authors.affiliation: Department of Pathology, School of Medicine, Kurume University, 67 Asahi-machi, Kurume-shi, Fukuoka-ken Japan.
authors.forename: Kouichi
authors.initials: K
authors.lastname: Ohshima
authors.affiliation: Institute for Virus Research, Kyoto University, 53 Asahi-machi, Kurume-shi, Fukuoka-ken Japan.
authors.forename: Masao
authors.initials: M
authors.lastname: Matsuoka
authors.affiliation: Laboratório de biologia molecular -Fundação pró-sangue, Av. Dr. Enéas de Carvalho Aguiar, 155, São Paulo, Brazil.
authors.forename: Ester Cerdeira
authors.initials: EC
authors.lastname: Sabino
authors.affiliation: Laboratório de biologia molecular -Fundação pró-sangue, Av. Dr. Enéas de Carvalho Aguiar, 155, São Paulo, Brazil.
authors.forename: Suzete Cleusa
authors.initials: SC
authors.lastname: Ferreira
authors.affiliation: Laboratório de biologia molecular -Fundação pró-sangue, Av. Dr. Enéas de Carvalho Aguiar, 155, São Paulo, Brazil.
authors.forename: Anna Shoko
authors.initials: AS
authors.lastname: Nishya
authors.affiliation: Instituto do Câncer do Estado de São Paulo, Av. Dr. Arnaldo, 251, São Paulo, Brazil.
authors.forename: Renata
authors.initials: R
authors.lastname: de Oliveira Costa
authors.affiliation: Pathology Section - Instituto de Infectologia Emílio Ribas, Av. Dr. Arnaldo, 165, São Paulo, Brazil.
authors.forename: Edenilson Eduardo
authors.initials: EE
authors.lastname: Calore
authors.affiliation: Pathology Section - Instituto de Infectologia Emílio Ribas, Av. Dr. Arnaldo, 165, São Paulo, Brazil.
authors.forename: Nilda Maria
authors.initials: NM
authors.lastname: Perez
authors.affiliation: Faculdade de Medicina - Programa de Ciências Médicas, Universidade de São Paulo, Av. Dr. Arnaldo, 455, São Paulo, Brazil ; Instituto do Câncer do Estado de São Paulo, Av. Dr. Arnaldo, 251, São Paulo, Brazil ; Laboratório de Imunopatologia, Prédio de Ambulatórios do Hospital das Clinicas, Av. Dr. Enéas de Carvalho Aguiar, 255, 1º.andar, bloco 12 sala 61, Cep: 05403 - 001, São Paulo, Brazil.
authors.forename: Juliana
authors.initials: J
authors.lastname: Pereira
keywords: Aids-related lymphoma; EBV; HIV
references.citation: J Med Virol. 2005 Jan;75(1):59-69
references.pmid: 15543571
references.citation: Semin Oncol. 2000 Aug;27(4):390-401
references.pmid: 10950365
references.citation: J Clin Oncol. 1999 Apr;17(4):1244
references.pmid: 10561185
references.citation: Blood. 2001 Jul 1;98(1):146-55
references.pmid: 11418474
references.citation: Leuk Lymphoma. 2010 Jan;51(1):66-72
references.pmid: 19860616
references.citation: Mediterr J Hematol Infect Dis. 2009 Dec 29;1(2):e2009032
references.pmid: 21416008
references.citation: J Med Virol. 2002 Jul;67(3):320-6
references.pmid: 12116021
references.citation: J Infect Dis. 2002 Aug 1;186(3):405-9
references.pmid: 12134237
references.citation: Oncogene. 2003 Aug 11;22(33):5108-21
references.pmid: 12910248
references.citation: J Clin Virol. 2006 Aug;36(4):258-63
references.pmid: 16762591
references.citation: Ann Hematol. 2010 Jan;89(1):45-51
references.pmid: 19495752
references.citation: APMIS. 2011 Apr;119(4-5):309-16
references.pmid: 21492232